Medical Advisory Committee
Our Medical Advisory Committee plays a key role in ensuring our research strategy and annual grant programs are aligned with our mission – funding innovative research initiatives in pursuit of new treatment options -- and ultimately a cure -- for myeloproliferative neoplasms (MPNs).
Medical Advisory Committee
Dr. Linda Foltz
Dr. Foltz is also a Clinical Associate Professor in the UBC Division of Hematology.
She joined the Division of Hematology at St. Paul’s Hospital in Vancouver in 2007, and was the Head its Division of Hematology from 2013-2018.
Dr. Foltz completed medical school, internal medicine residency training and hematology subspecialty fellowship at the University of British Columbia.
Her area of special interest is myeloproliferative neoplasms (MPN). She is also a principal investigator for MPN clinical trials, and is a founding and executive member of the Canadian MPN Group.
Dr. Shireen Sirhan
Dr. Sirhan is a Hematologist and Medical Oncologist, as well as an assistant professor at McGill University.
Together with Dr. Jaroslav Prchal, she established the first myeloproliferative neoplasms clinic in Canada at the Jewish General Hospital in Montreal.
She completed her medical school, internal medicine and Hematology and Oncology training at McGill University. She
further trained in myeloproliferative neoplasms with Dr. Tefferi at the Mayo clinic. She also holds a masters degree in Clinical trials from the University of London.She is a founding and executive member of the Canadian MPN Group, and the vice president of research—MPNs for Groupe québécois de recherche en LMC-NMP.
She has authored several publication in the area of MPN clinical research and has been an investigator on several clinical trials assessing novel agents in the treatment of MPNs.
Dr. Elena Liew
Dr. Liew is currently an appointed clinical assistant professor in the Division of Hematology at the University of Alberta.
Dr. Elena Liew is an alumna of the University of Alberta medical school and completed her internal medicine there as well. She went on to complete hematology subspecialty training at the University of Calgary and this was followed by a leukemia fellowship at Princess Margaret Hospital in Toronto.
Her clinical focus is on myeloid disorders, and she is the local principal investigator for several MPN-related clinical trials.
Nancy Siddiqi, RN
Ms Siddiqi's clinical focus is on myeloid disorders, and she is the local principal investigator for several MPN-related clinical trials.
18 Nursewood Rd
Tel: 844 644 6766
Our Mission is to stimulate original Canadian research in pursuit of new treatment options - and ultimately a cure - for the blood cancers collectively known as myeloproliferative neoplasms (MPNs).
CRA Registered Charity # 748799723 RR 001